WO2009015799A3 - Detection of platinum resistance - Google Patents

Detection of platinum resistance Download PDF

Info

Publication number
WO2009015799A3
WO2009015799A3 PCT/EP2008/005965 EP2008005965W WO2009015799A3 WO 2009015799 A3 WO2009015799 A3 WO 2009015799A3 EP 2008005965 W EP2008005965 W EP 2008005965W WO 2009015799 A3 WO2009015799 A3 WO 2009015799A3
Authority
WO
WIPO (PCT)
Prior art keywords
platinum
detection
platinum resistance
patient
sensitive
Prior art date
Application number
PCT/EP2008/005965
Other languages
German (de)
French (fr)
Other versions
WO2009015799A2 (en
Inventor
Michael Bonin
Jessica Hoffmann
Michael Walter
Olaf Riess
Hans Neubauer
Tanja Fehm
Erich Solomayer
Diethelm Wallwiener
Karl Sotlar
Original Assignee
Univ Eberhard Karls
Michael Bonin
Jessica Hoffmann
Michael Walter
Olaf Riess
Hans Neubauer
Tanja Fehm
Erich Solomayer
Diethelm Wallwiener
Karl Sotlar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Eberhard Karls, Michael Bonin, Jessica Hoffmann, Michael Walter, Olaf Riess, Hans Neubauer, Tanja Fehm, Erich Solomayer, Diethelm Wallwiener, Karl Sotlar filed Critical Univ Eberhard Karls
Publication of WO2009015799A2 publication Critical patent/WO2009015799A2/en
Publication of WO2009015799A3 publication Critical patent/WO2009015799A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

The invention relates to a method for classifying a patient as platinum-sensitive or platinum-resistant, the use of the expression profile of a subgroup of genes for classifying a patient as platinum-sensitive or platinum-resistant, and a method for identifying informative genes in order to be able to classify a patient as platinum-sensitive or platinum-resistant.
PCT/EP2008/005965 2007-07-27 2008-07-21 Detection of platinum resistance WO2009015799A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007036404.2 2007-07-27
DE200710036404 DE102007036404A1 (en) 2007-07-27 2007-07-27 Detection of platinum resistance

Publications (2)

Publication Number Publication Date
WO2009015799A2 WO2009015799A2 (en) 2009-02-05
WO2009015799A3 true WO2009015799A3 (en) 2009-06-11

Family

ID=40104652

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/005965 WO2009015799A2 (en) 2007-07-27 2008-07-21 Detection of platinum resistance

Country Status (2)

Country Link
DE (1) DE102007036404A1 (en)
WO (1) WO2009015799A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019268A1 (en) * 2004-03-26 2006-01-26 Research Development Foundation Molecular markers of cisplatin resistance in cancer and uses thereof
US20060094012A1 (en) * 2002-07-31 2006-05-04 University Of Southern California Polymorphisms for predicting disease and treatment outcome

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094012A1 (en) * 2002-07-31 2006-05-04 University Of Southern California Polymorphisms for predicting disease and treatment outcome
US20060019268A1 (en) * 2004-03-26 2006-01-26 Research Development Foundation Molecular markers of cisplatin resistance in cancer and uses thereof

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
AGARWAL ET AL: "Expression profiling and individualisation of treatment for ovarian cancer", CURRENT OPINION IN PHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 6, no. 4, 1 August 2006 (2006-08-01), pages 345 - 349, XP005539061, ISSN: 1471-4892 *
BERNARDINI M ET AL: "HIGH-RESOLUTION MAPPING OF GENOMIC IMBALANCE AND IDENTIFICATION OF GENE EXPRESSION PROFILES ASSOCAITED WITH DIFFERENTIAL CHEMOTHERAPY RESPONSE IN SEROUS EPITHELIAL OVARIAN CANCER", NEOPLASIA, DOYMA, BARCELONA, ES, vol. 7, no. 6, 1 June 2005 (2005-06-01), pages 603 - 613, XP008068059, ISSN: 0212-9787 *
CHEN Z ET AL: "CORRELATION OF CISPLATIN SENSITIVITY WITH DIFFERENTIAL ALTERATION OF EGFR EXPRESSION IN HEAD AND NECK CANCER CELLS", ANTICANCER RESEARCH, HELENIC ANTICANCER INSTITUTE, ATHENS, vol. 20, no. 2A, 1 March 2000 (2000-03-01), pages 899 - 902, XP009012770, ISSN: 0250-7005 *
DAHL EDGAR ET AL: "Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 JUL 2006, vol. 12, no. 13, 1 July 2006 (2006-07-01), pages 3950 - 3960, XP002508551, ISSN: 1078-0432 *
DE SMET F ET AL: "Predicting the clinical behavior of ovarian cancer from gene expression profiles.", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER : OFFICIAL JOURNAL OF THE INTERNATIONAL GYNECOLOGICAL CANCER SOCIETY 2006 JAN-FEB, vol. 16 Suppl 1, January 2006 (2006-01-01), pages 147 - 151, XP002508552, ISSN: 1048-891X *
DRESSMAN HOLLY K ET AL: "An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.", JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY 10 FEB 2007, vol. 25, no. 5, 10 February 2007 (2007-02-10), pages 517 - 525, XP002519673, ISSN: 1527-7755 *
FEHRMANN RUDOLF S N ET AL: "Profiling studies in ovarian cancer: a review.", THE ONCOLOGIST AUG 2007, vol. 12, no. 8, August 2007 (2007-08-01), pages 960 - 966, XP002519672, ISSN: 1083-7159 *
HELLEMAN JOZIEN ET AL: "Molecular profiling of platinum resistant ovarian cancer.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 15 APR 2006, vol. 118, no. 8, 15 April 2006 (2006-04-15), pages 1963 - 1971, XP002519674, ISSN: 0020-7136 *
KOMATSU MASAAKI ET AL: "Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers.", MOLECULAR CANCER THERAPEUTICS MAR 2006, vol. 5, no. 3, March 2006 (2006-03-01), pages 767 - 775, XP002519676, ISSN: 1535-7163 *
MACLEOD KENNETH ET AL: "Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer", CANCER RESEARCH, vol. 65, no. 15, August 2005 (2005-08-01), pages 6789 - 6800, XP002519751, ISSN: 0008-5472 *
PETERS DAVID ET AL: "Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells.", MOLECULAR CANCER THERAPEUTICS OCT 2005, vol. 4, no. 10, October 2005 (2005-10-01), pages 1605 - 1616, XP002519675, ISSN: 1535-7163 *
RICHARDSON ET AL: "Drug resistance in ovarian cancer: The emerging importance of gene transcription and spatio-temporal regulation of resistance", DRUG RESISTANCE UPDATES, CHURCHILL LIVINGSTONE, EDINBURGH, GB, vol. 8, no. 5, 1 October 2005 (2005-10-01), pages 311 - 321, XP005182400, ISSN: 1368-7646 *
ROBERTS D ET AL: "Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells", BRITISH JOURNAL OF CANCER, vol. 92, no. 6, 28 March 2005 (2005-03-28), pages 1149 - 1158, XP002519671, ISSN: 0007-0920 *
TAKEUCHI ET AL: "Cloning and characterization of DPPL1 and DPPL2, representatives of a novel type of mammalian phosphatidate phosphatase", GENE, ELSEVIER, AMSTERDAM, NL, vol. 399, no. 2, 2 June 2007 (2007-06-02), pages 174 - 180, XP022190607, ISSN: 0378-1119 *

Also Published As

Publication number Publication date
DE102007036404A1 (en) 2009-01-29
WO2009015799A2 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
MX2010003424A (en) Measuring mechanical properties.
EP2164086A4 (en) Indicator, detector, and detection method
WO2011065980A3 (en) Dyes for analysis of protein aggregation
GB2481950B (en) Surface microstructure measurement method, surface microstructure measurement data analysis method and surface microstructure measurement system.
EP2215541A4 (en) Pre-load force sensing resistor and method
WO2008031041A3 (en) Melanoma gene signature
WO2009048673A3 (en) Stochastic confinement to detect, manipulate, and utilize molecules and organisms
EP2076118A4 (en) Bedbug detection, monitoring and control techniques
WO2010077304A3 (en) Methods for the characterization of microorganisms on solid or semi-solid media
WO2012009644A3 (en) Methods to identify synthetic and natural rna elements that enhance protein translation
WO2011087789A3 (en) Methods for the detection of microorganisms
EP2216747A3 (en) Method and apparatus to associate demographic and geographic information with influential consumer relationships
BRPI0814416A2 (en) MICROBIOLOGICAL DETECTION METHOD
EP2229028B8 (en) Biological sample measurement apparatus and biological sample measurement system equipped with same
NZ592994A (en) Diagnostic test for Streptococcus equi comprising assessing the presence or absence of the S. equi eqbE gene
HK1142675A1 (en) Method for improving the ability to detect materials in an x-ray test system, and x-ray test system
WO2010075360A3 (en) Methods for detection of sepsis
NZ589251A (en) Novel marker for detection of bladder cancer
WO2012082406A3 (en) Location aware spreadsheet actions
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
WO2012024546A3 (en) Incorporation of health measurments in analysis and interpretation of functional biological response data
EP2208795A4 (en) Nucleic acid detection method, and nucleic acid detection kit
WO2011017419A3 (en) Systems and methods for monitoring corrosion in a well
WO2009100447A3 (en) Detection of degradative enzymes and biomolecules in bodily fluids
WO2011003623A3 (en) Method and marker for the individual prognosis and/or the individual detection of neuropathy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08784930

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08784930

Country of ref document: EP

Kind code of ref document: A2